epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atoncy
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
avasopasem
Avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
Awiqli (insulin icodec-abae)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Winrevair (sotatercept-csrk)

sotatercept

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  INJ

Special Note

[drug name clarification]
Info: nonproprietary name = sotatercept-csrk

pulmonary arterial HTN

[0.7 mg/kg/dose SC q3wk]
Start: 0.3 mg/kg/dose SC x1; Info: hold tx for at least 3wk if Hgb incr. >2 g/dL from previous dose and >ULN, if Hgb incr. >4 g/dL from baseline, if Hgb incr. >2 g/dL above ULN, or if Plt <50,000; reinitiate tx at 0.3 mg/kg/dose SC x1 if tx delay >9wk

renal dosing

[no adjustment]
renal impairment: no adjustment
HD/PD: no adjustment; no supplement

hepatic dosing

[not defined]

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@337f248a
  • hypersensitivity to drug or ingredient
  • Plt <50,000
  • bleeding, severe
  • pregnancy
  • avoid: breastfeeding during tx and x4mo after D/C
  • caution: patients of childbearing potential

Drug Interactions .

Overview

sotatercept

activin signaling inhibitor

Interaction Characteristics:
  • antiplatelet effects
  • thrombogenic effects

Avoid/Use Alternative

  • enoxaparin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    enoxaparin
    1 interaction

    Avoid/Use Alternative

    sotatercept + enoxaparin

    use alternative or monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • fondaparinux
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    fondaparinux
    1 interaction

    Avoid/Use Alternative

    sotatercept + fondaparinux

    use alternative or monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • tranexamic acid
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    tranexamic acid
    1 interaction

    Avoid/Use Alternative

    sotatercept + tranexamic acid

    avoid combo: combo may incr. risk of thromboembolism (additive effects)

Monitor/Modify Tx

  • abemaciclib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    abemaciclib
    1 interaction

    Monitor/Modify Tx

    sotatercept + abemaciclib

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • abrocitinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    abrocitinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + abrocitinib

    monitor Hgb, platelets, bleeding or thrombosis s/sx, especially during abrocitinib tx initiation or if abrocitinib 200 mg/day: combo may incr. risk of bleeding (including severe), thromboembolism (additive effects)

  • acalabrutinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    acalabrutinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + acalabrutinib

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • ado-trastuzumab emtansine
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ado-trastuzumab emtansine
    1 interaction

    Monitor/Modify Tx

    sotatercept + ado-trastuzumab emtansine

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe or life-threatening (additive effects)

  • afatinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    afatinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + afatinib

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe or life-threatening (additive effects)

  • aflibercept
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    aflibercept
    1 interaction

    Monitor/Modify Tx

    sotatercept + aflibercept

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • alpha-tocopherol (vitamin E)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    alpha-tocopherol (vitamin E)
    1 interaction

    Monitor/Modify Tx

    sotatercept + alpha-tocopherol (vitamin E)

    monitor platelets, bleeding signs/symptoms, especially with alpha-tocopherol doses >800 units/day: combo may increase risk of bleeding, including severe (additive effects)

  • alprostadil intracavernous
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    alprostadil intracavernous
    1 interaction

    Monitor/Modify Tx

    sotatercept + alprostadil intracavernous

    monitor injection site bleeding signs/symptoms: combo may increase risk of localized bleeding (additive effects)

  • alprostadil intravenous
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    alprostadil intravenous
    1 interaction

    Monitor/Modify Tx

    sotatercept + alprostadil intravenous

    monitor platelets, bleeding signs/symptoms: combo may increase risk of bleeding, including severe (additive effects)

  • alteplase
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    alteplase
    1 interaction

    Monitor/Modify Tx

    sotatercept + alteplase

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • aminocaproic acid
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    aminocaproic acid
    1 interaction

    Monitor/Modify Tx

    sotatercept + aminocaproic acid

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • anacaulase topical
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    anacaulase topical
    1 interaction

    Monitor/Modify Tx

    sotatercept + anacaulase topical

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • anagrelide
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    anagrelide
    1 interaction

    Monitor/Modify Tx

    sotatercept + anagrelide

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • angiotensin II
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    angiotensin II
    1 interaction

    Monitor/Modify Tx

    sotatercept + angiotensin II

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • anthrax immune globulin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    anthrax immune globulin
    1 interaction

    Monitor/Modify Tx

    sotatercept + anthrax immune globulin

    monitor Hgb, thrombosis s/sx; use lowest anthrax immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • anti-inhibitor coagulant complex
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    anti-inhibitor coagulant complex
    1 interaction

    Monitor/Modify Tx

    sotatercept + anti-inhibitor coagulant complex

    monitor Hgb, thrombosis s/sx, especially w/ anti-inhibitor coagulant complex dose >100 units/kg: combo may incr. risk of thromboembolism (additive effects)

  • antihemophilic factor (factor VIII)/von Willebrand factor complex
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    antihemophilic factor (factor VIII)/ von Willebrand factor complex
    1 interaction

    Monitor/Modify Tx

    sotatercept + antihemophilic factor (factor VIII)/ von Willebrand factor complex

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • antithrombin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    antithrombin
    1 interaction

    Monitor/Modify Tx

    sotatercept + antithrombin

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • apixaban
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    apixaban
    1 interaction

    Monitor/Modify Tx

    sotatercept + apixaban

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • argatroban
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    argatroban
    1 interaction

    Monitor/Modify Tx

    sotatercept + argatroban

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • asciminib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    sotatercept + asciminib

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • asparaginase
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    asparaginase
    1 interaction

    Monitor/Modify Tx

    sotatercept + asparaginase

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of bleeding (including severe), thromboembolism (additive effects)

  • aspirin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    aspirin
    1 interaction

    Monitor/Modify Tx

    sotatercept + aspirin

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe or life-threatening (additive effects)

  • atidarsagene autotemcel
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    atidarsagene autotemcel
    1 interaction

    Monitor/Modify Tx

    sotatercept + atidarsagene autotemcel

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • avapritinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    avapritinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + avapritinib

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • avatrombopag
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    avatrombopag
    1 interaction

    Monitor/Modify Tx

    sotatercept + avatrombopag

    monitor Hgb, platelets, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • axitinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + axitinib

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • baricitinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    baricitinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + baricitinib

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • bazedoxifene
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    bazedoxifene
    1 interaction

    Monitor/Modify Tx

    sotatercept + bazedoxifene

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • bevacizumab
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    sotatercept + bevacizumab

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • binimetinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    binimetinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + binimetinib

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • bivalirudin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    bivalirudin
    1 interaction

    Monitor/Modify Tx

    sotatercept + bivalirudin

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • botulism immune globulin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    botulism immune globulin
    1 interaction

    Monitor/Modify Tx

    sotatercept + botulism immune globulin

    monitor Hgb, thrombosis s/sx; use lowest botulism immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • brentuximab vedotin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    brentuximab vedotin
    1 interaction

    Monitor/Modify Tx

    sotatercept + brentuximab vedotin

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • brolucizumab
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    brolucizumab
    1 interaction

    Monitor/Modify Tx

    sotatercept + brolucizumab

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • bromelain
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    bromelain
    1 interaction

    Monitor/Modify Tx

    sotatercept + bromelain

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • bromfenac ophthalmic
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    bromfenac ophthalmic
    1 interaction

    Monitor/Modify Tx

    sotatercept + bromfenac ophthalmic

    monitor platelets, bleeding s/sx: combo may incr. risk of postop ocular bleeding (additive effects)

  • C1 esterase inhibitor
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    C1 esterase inhibitor
    1 interaction

    Monitor/Modify Tx

    sotatercept + C1 esterase inhibitor

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • cabazitaxel
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    cabazitaxel
    1 interaction

    Monitor/Modify Tx

    sotatercept + cabazitaxel

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe or life-threatening (additive effects)

  • cabozantinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + cabozantinib

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • calaspargase
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    calaspargase
    1 interaction

    Monitor/Modify Tx

    sotatercept + calaspargase

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of bleeding (including severe), thromboembolism (additive effects)

  • cangrelor
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    cangrelor
    1 interaction

    Monitor/Modify Tx

    sotatercept + cangrelor

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • caplacizumab
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    caplacizumab
    1 interaction

    Monitor/Modify Tx

    sotatercept + caplacizumab

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • carfilzomib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    sotatercept + carfilzomib

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • celecoxib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    sotatercept + celecoxib

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective celecoxib dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • chorionic gonadotropin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    chorionic gonadotropin
    1 interaction

    Monitor/Modify Tx

    sotatercept + chorionic gonadotropin

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • cilostazol
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    cilostazol
    1 interaction

    Monitor/Modify Tx

    sotatercept + cilostazol

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • citalopram
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    citalopram
    1 interaction

    Monitor/Modify Tx

    sotatercept + citalopram

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • clopidogrel
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    clopidogrel
    1 interaction

    Monitor/Modify Tx

    sotatercept + clopidogrel

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • clozapine
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    clozapine
    1 interaction

    Monitor/Modify Tx

    sotatercept + clozapine

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • coagulation factor IX
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    coagulation factor IX
    1 interaction

    Monitor/Modify Tx

    sotatercept + coagulation factor IX

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • coagulation factor VIIa
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    coagulation factor VIIa
    1 interaction

    Monitor/Modify Tx

    sotatercept + coagulation factor VIIa

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • coagulation factor XIII A-subunit
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    coagulation factor XIII A-subunit
    1 interaction

    Monitor/Modify Tx

    sotatercept + coagulation factor XIII A-subunit

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • collagenase clostridium histolyticum
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    collagenase clostridium histolyticum
    1 interaction

    Monitor/Modify Tx

    sotatercept + collagenase clostridium histolyticum

    monitor injection site bleeding s/sx: combo may incr. risk of localized bleeding, including severe (additive effects)

  • concizumab
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    concizumab
    1 interaction

    Monitor/Modify Tx

    sotatercept + concizumab

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • cysteamine
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    cysteamine
    1 interaction

    Monitor/Modify Tx

    sotatercept + cysteamine

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe (additive effects)

  • cytomegalovirus immune globulin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    cytomegalovirus immune globulin
    1 interaction

    Monitor/Modify Tx

    sotatercept + cytomegalovirus immune globulin

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • dabigatran
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    dabigatran
    1 interaction

    Monitor/Modify Tx

    sotatercept + dabigatran

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • dalteparin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    dalteparin
    1 interaction

    Monitor/Modify Tx

    sotatercept + dalteparin

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • danazol
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    sotatercept + danazol

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • danshen
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    danshen
    1 interaction

    Monitor/Modify Tx

    sotatercept + danshen

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • darbepoetin alfa
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    sotatercept + darbepoetin alfa

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • dasatinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    dasatinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + dasatinib

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • deferasirox
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    deferasirox
    1 interaction

    Monitor/Modify Tx

    sotatercept + deferasirox

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe or life-threatening (additive effects)

  • defibrotide
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    defibrotide
    1 interaction

    Monitor/Modify Tx

    sotatercept + defibrotide

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • deflazacort
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    deflazacort
    1 interaction

    Monitor/Modify Tx

    sotatercept + deflazacort

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • desogestrel (contraceptive)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    desogestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    sotatercept + desogestrel (contraceptive)

    monitor Hgb, thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • desvenlafaxine
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    desvenlafaxine
    1 interaction

    Monitor/Modify Tx

    sotatercept + desvenlafaxine

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • deuruxolitinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    deuruxolitinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + deuruxolitinib

    monitor bleeding or thrombosis s/sx: combo may incr. risk of thromboembolism, GI or other bleeding, including severe (additive effects)

  • dexamethasone
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    dexamethasone
    1 interaction

    Monitor/Modify Tx

    sotatercept + dexamethasone

    monitor Hgb, thrombosis s/sx, especially if multiple myeloma use: combo may incr. risk of thromboembolism (additive effects)

  • diclofenac
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    sotatercept + diclofenac

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective diclofenac dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • diclofenac ophthalmic
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    diclofenac ophthalmic
    1 interaction

    Monitor/Modify Tx

    sotatercept + diclofenac ophthalmic

    monitor platelets, bleeding s/sx: combo may incr. risk of postop ocular bleeding (additive effects)

  • diclofenac topical
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    sotatercept + diclofenac topical

    monitor platelets, bleeding or thrombosis s/sx; use lowest effective diclofenac dose, shortest effective tx duration: combo may incr. risk of thromboembolism, GI or other bleeding, including severe or life-threatening (additive effects)

  • dienogest (contraceptive)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    dienogest (contraceptive)
    1 interaction

    Monitor/Modify Tx

    sotatercept + dienogest (contraceptive)

    monitor Hgb, thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • diflunisal
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    sotatercept + diflunisal

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective diflunisal dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • dimethyl fumarate
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    dimethyl fumarate
    1 interaction

    Monitor/Modify Tx

    sotatercept + dimethyl fumarate

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe or life-threatening (additive effects)

  • diosmin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    diosmin
    1 interaction

    Monitor/Modify Tx

    sotatercept + diosmin

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • dipyridamole
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    dipyridamole
    1 interaction

    Monitor/Modify Tx

    sotatercept + dipyridamole

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • diroximel fumarate
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    diroximel fumarate
    1 interaction

    Monitor/Modify Tx

    sotatercept + diroximel fumarate

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe or life-threatening (additive effects)

  • drospirenone (contraceptive)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    drospirenone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    sotatercept + drospirenone (contraceptive)

    monitor Hgb, thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • drospirenone (hormone replacement)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    drospirenone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    sotatercept + drospirenone (hormone replacement)

    monitor Hgb, thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • duloxetine
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    duloxetine
    1 interaction

    Monitor/Modify Tx

    sotatercept + duloxetine

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • edoxaban
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    edoxaban
    1 interaction

    Monitor/Modify Tx

    sotatercept + edoxaban

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • eltrombopag
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    eltrombopag
    1 interaction

    Monitor/Modify Tx

    sotatercept + eltrombopag

    monitor Hgb, platelets, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • encorafenib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    encorafenib
    1 interaction

    Monitor/Modify Tx

    sotatercept + encorafenib

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe or life-threatening (additive effects)

  • epirubicin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    epirubicin
    1 interaction

    Monitor/Modify Tx

    sotatercept + epirubicin

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • epoetin alfa
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    epoetin alfa
    1 interaction

    Monitor/Modify Tx

    sotatercept + epoetin alfa

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • epoprostenol
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    epoprostenol
    1 interaction

    Monitor/Modify Tx

    sotatercept + epoprostenol

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • eptifibatide
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    eptifibatide
    1 interaction

    Monitor/Modify Tx

    sotatercept + eptifibatide

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • erlotinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    erlotinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + erlotinib

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe or life-threatening (additive effects)

  • escitalopram
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    escitalopram
    1 interaction

    Monitor/Modify Tx

    sotatercept + escitalopram

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • estetrol (contraceptive)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    sotatercept + estetrol (contraceptive)

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • estradiol (contraceptive)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    sotatercept + estradiol (contraceptive)

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • estradiol (hormone replacement)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    estradiol (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    sotatercept + estradiol (hormone replacement)

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • estrogens, conjugated (hormone replacement)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    estrogens, conjugated (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    sotatercept + estrogens, conjugated (hormone replacement)

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • estrogens, esterified (hormone replacement)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    estrogens, esterified (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    sotatercept + estrogens, esterified (hormone replacement)

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ethanol (alcoholic beverage)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Monitor/Modify Tx

    sotatercept + ethanol (alcoholic beverage)

    monitor platelets, bleeding signs/symptoms: combo may incr. risk of GI or other bleeding, including severe (additive effects)

  • ethinyl estradiol (contraceptive)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    sotatercept + ethinyl estradiol (contraceptive)

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ethinyl estradiol (hormone replacement)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ethinyl estradiol (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    sotatercept + ethinyl estradiol (hormone replacement)

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ethynodiol (contraceptive)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ethynodiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    sotatercept + ethynodiol (contraceptive)

    monitor Hgb, thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • etodolac
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    sotatercept + etodolac

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective etodolac dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • etonogestrel (contraceptive)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    etonogestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    sotatercept + etonogestrel (contraceptive)

    monitor Hgb, thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • evening primrose oil
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    evening primrose oil
    1 interaction

    Monitor/Modify Tx

    sotatercept + evening primrose oil

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • everolimus
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    everolimus
    1 interaction

    Monitor/Modify Tx

    sotatercept + everolimus

    monitor Hgb, thrombosis s/sx, especially if immunosuppressant use: combo may incr. risk of thromboembolism (additive effects)

  • factor XIII concentrate
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    factor XIII concentrate
    1 interaction

    Monitor/Modify Tx

    sotatercept + factor XIII concentrate

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • faricimab
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    faricimab
    1 interaction

    Monitor/Modify Tx

    sotatercept + faricimab

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fedratinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    fedratinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + fedratinib

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fenofibrate
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    fenofibrate
    1 interaction

    Monitor/Modify Tx

    sotatercept + fenofibrate

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fenofibric acid
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    fenofibric acid
    1 interaction

    Monitor/Modify Tx

    sotatercept + fenofibric acid

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fenoprofen
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    sotatercept + fenoprofen

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective fenoprofen dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • fenugreek
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    fenugreek
    1 interaction

    Monitor/Modify Tx

    sotatercept + fenugreek

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • fibrinogen (human)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    fibrinogen (human)
    1 interaction

    Monitor/Modify Tx

    sotatercept + fibrinogen (human)

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fitusiran
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    fitusiran
    1 interaction

    Monitor/Modify Tx

    sotatercept + fitusiran

    monitor antithrombin activity level, Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fluoxetine
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    fluoxetine
    1 interaction

    Monitor/Modify Tx

    sotatercept + fluoxetine

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • flurbiprofen
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    sotatercept + flurbiprofen

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective flurbiprofen dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • flurbiprofen ophthalmic
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    flurbiprofen ophthalmic
    1 interaction

    Monitor/Modify Tx

    sotatercept + flurbiprofen ophthalmic

    monitor platelets, bleeding s/sx: combo may incr. risk of postop ocular bleeding (additive effects)

  • fluvoxamine
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    fluvoxamine
    1 interaction

    Monitor/Modify Tx

    sotatercept + fluvoxamine

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • follitropin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    follitropin
    1 interaction

    Monitor/Modify Tx

    sotatercept + follitropin

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • fruquintinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + fruquintinib

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • garlic
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    garlic
    1 interaction

    Monitor/Modify Tx

    sotatercept + garlic

    monitor platelets, bleeding s/sx, especially w/ supplemental garlic; dietary intake OK: combo may incr. risk of bleeding, including severe (additive effects)

  • gefitinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    gefitinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + gefitinib

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe or life-threatening (additive effects)

  • gemtuzumab ozogamicin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    gemtuzumab ozogamicin
    1 interaction

    Monitor/Modify Tx

    sotatercept + gemtuzumab ozogamicin

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • ginkgo
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ginkgo
    1 interaction

    Monitor/Modify Tx

    sotatercept + ginkgo

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • heparin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    heparin
    1 interaction

    Monitor/Modify Tx

    sotatercept + heparin

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • hepatitis B immune globulin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    hepatitis B immune globulin
    1 interaction

    Monitor/Modify Tx

    sotatercept + hepatitis B immune globulin

    monitor Hgb, thrombosis s/sx; use lowest hepatitis B immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • hydrocortisone
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    sotatercept + hydrocortisone

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe (additive effects)

  • ibrutinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ibrutinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + ibrutinib

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • ibuprofen
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    sotatercept + ibuprofen

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective ibuprofen dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • ibuprofen lysine
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ibuprofen lysine
    1 interaction

    Monitor/Modify Tx

    sotatercept + ibuprofen lysine

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects)

  • icosapent ethyl
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    icosapent ethyl
    1 interaction

    Monitor/Modify Tx

    sotatercept + icosapent ethyl

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • imatinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    imatinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + imatinib

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe (additive effects)

  • immune globulin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    immune globulin
    1 interaction

    Monitor/Modify Tx

    sotatercept + immune globulin

    monitor Hgb, thrombosis s/sx; use lowest immune globulin dose, concentration and infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • indomethacin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    sotatercept + indomethacin

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective indomethacin dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • iodixanol
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    iodixanol
    1 interaction

    Monitor/Modify Tx

    sotatercept + iodixanol

    monitor Hgb, thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • iohexol
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    iohexol
    1 interaction

    Monitor/Modify Tx

    sotatercept + iohexol

    if IV iohexol use, monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • iomeprol
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    iomeprol
    1 interaction

    Monitor/Modify Tx

    sotatercept + iomeprol

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • iopamidol
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    iopamidol
    1 interaction

    Monitor/Modify Tx

    sotatercept + iopamidol

    if IV iopamidol use, monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • iopromide
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    iopromide
    1 interaction

    Monitor/Modify Tx

    sotatercept + iopromide

    monitor Hgb, thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • iothalamate meglumine
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    iothalamate meglumine
    1 interaction

    Monitor/Modify Tx

    sotatercept + iothalamate meglumine

    if IV iothalamate meglumine use, monitor Hgb, thrombosis signs/symptoms; retrograde cystography and cystourethrography use OK: combo may incr. risk of thromboembolism (additive effects)

  • ioversol
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ioversol
    1 interaction

    Monitor/Modify Tx

    sotatercept + ioversol

    monitor Hgb, thrombosis signs/symptoms: combo may incr. risk of thromboembolism (additive effects)

  • ketoprofen
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    sotatercept + ketoprofen

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective ketoprofen dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • ketorolac
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    sotatercept + ketorolac

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective ketorolac dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • ketorolac ophthalmic
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ketorolac ophthalmic
    1 interaction

    Monitor/Modify Tx

    sotatercept + ketorolac ophthalmic

    monitor platelets, bleeding s/sx: combo may incr. risk of postop ocular bleeding (additive effects)

  • lazertinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    lazertinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + lazertinib

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • lenalidomide
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    lenalidomide
    1 interaction

    Monitor/Modify Tx

    sotatercept + lenalidomide

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • lenvatinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + lenvatinib

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • levomilnacipran
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    levomilnacipran
    1 interaction

    Monitor/Modify Tx

    sotatercept + levomilnacipran

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • levonorgestrel (contraceptive)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    levonorgestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    sotatercept + levonorgestrel (contraceptive)

    monitor Hgb, thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • levonorgestrel (hormone replacement)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    levonorgestrel (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    sotatercept + levonorgestrel (hormone replacement)

    monitor Hgb, thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • lifileucel
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    lifileucel
    1 interaction

    Monitor/Modify Tx

    sotatercept + lifileucel

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • luspatercept
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    sotatercept + luspatercept

    if beta thalassemia use, monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • lusutrombopag
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    lusutrombopag
    1 interaction

    Monitor/Modify Tx

    sotatercept + lusutrombopag

    monitor Hgb, platelets, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • magnesium salicylate
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    sotatercept + magnesium salicylate

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe (additive effects)

  • meclofenamate
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    sotatercept + meclofenamate

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective meclofenamate dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • medroxyprogesterone (contraceptive)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    medroxyprogesterone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    sotatercept + medroxyprogesterone (contraceptive)

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • medroxyprogesterone (hormone replacement)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    medroxyprogesterone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    sotatercept + medroxyprogesterone (hormone replacement)

    monitor Hgb, thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • mefenamic acid
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    sotatercept + mefenamic acid

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective mefenamic acid dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • megestrol
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    megestrol
    1 interaction

    Monitor/Modify Tx

    sotatercept + megestrol

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • meloxicam
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    sotatercept + meloxicam

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective meloxicam dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • menotropins
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    menotropins
    1 interaction

    Monitor/Modify Tx

    sotatercept + menotropins

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • methotrexate
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    methotrexate
    1 interaction

    Monitor/Modify Tx

    sotatercept + methotrexate

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe or life-threatening (additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    sotatercept + methoxy polyethylene glycol-epoetin beta

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • methyl salicylate topical
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    methyl salicylate topical
    1 interaction

    Monitor/Modify Tx

    sotatercept + methyl salicylate topical

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects, systemic salicylate absorption may occur from topical use)

  • methyltestosterone
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    sotatercept + methyltestosterone

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • milnacipran
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    milnacipran
    1 interaction

    Monitor/Modify Tx

    sotatercept + milnacipran

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • mitotane
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    mitotane
    1 interaction

    Monitor/Modify Tx

    sotatercept + mitotane

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • momelotinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    momelotinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + momelotinib

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • monomethyl fumarate
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    monomethyl fumarate
    1 interaction

    Monitor/Modify Tx

    sotatercept + monomethyl fumarate

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe or life-threatening (additive effects)

  • mycophenolate mofetil
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    mycophenolate mofetil
    1 interaction

    Monitor/Modify Tx

    sotatercept + mycophenolate mofetil

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe (additive effects)

  • mycophenolic acid
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    mycophenolic acid
    1 interaction

    Monitor/Modify Tx

    sotatercept + mycophenolic acid

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe (additive effects)

  • nabumetone
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    sotatercept + nabumetone

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective nabumetone dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • naproxen
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    sotatercept + naproxen

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective naproxen dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • nattokinase
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    nattokinase
    1 interaction

    Monitor/Modify Tx

    sotatercept + nattokinase

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • necitumumab
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    necitumumab
    1 interaction

    Monitor/Modify Tx

    sotatercept + necitumumab

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • nepafenac ophthalmic
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    nepafenac ophthalmic
    1 interaction

    Monitor/Modify Tx

    sotatercept + nepafenac ophthalmic

    monitor platelets, bleeding s/sx: combo may incr. risk of postop ocular bleeding (additive effects)

  • niacin (vitamin B3)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    niacin (vitamin B3)
    1 interaction

    Monitor/Modify Tx

    sotatercept + niacin (vitamin B3)

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • nilotinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    nilotinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + nilotinib

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe or life-threatening (additive effects)

  • nintedanib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    nintedanib
    1 interaction

    Monitor/Modify Tx

    sotatercept + nintedanib

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • norelgestromin (contraceptive)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    norelgestromin (contraceptive)
    1 interaction

    Monitor/Modify Tx

    sotatercept + norelgestromin (contraceptive)

    monitor Hgb, thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • norethindrone (contraceptive)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    norethindrone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    sotatercept + norethindrone (contraceptive)

    monitor Hgb, thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • norethindrone (hormone replacement)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    norethindrone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    sotatercept + norethindrone (hormone replacement)

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • norgestimate (contraceptive)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    norgestimate (contraceptive)
    1 interaction

    Monitor/Modify Tx

    sotatercept + norgestimate (contraceptive)

    monitor Hgb, thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • norgestrel (contraceptive)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    norgestrel (contraceptive)
    1 interaction

    Monitor/Modify Tx

    sotatercept + norgestrel (contraceptive)

    monitor Hgb, thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • nusinersen
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    nusinersen
    1 interaction

    Monitor/Modify Tx

    sotatercept + nusinersen

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • obinutuzumab
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    sotatercept + obinutuzumab

    monitor platelets, Hgb, bleeding or thrombosis s/sx; consider holding sotatercept, especially during first obinutuzumab cycle: combo may incr. risk of thromboembolism, severe bleeding, including life-threatening (additive effects)

  • olaparib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    olaparib
    1 interaction

    Monitor/Modify Tx

    sotatercept + olaparib

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • omega-3-acid
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    omega-3-acid
    1 interaction

    Monitor/Modify Tx

    sotatercept + omega-3-acid

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • ospemifene
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ospemifene
    1 interaction

    Monitor/Modify Tx

    sotatercept + ospemifene

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • oxaliplatin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    oxaliplatin
    1 interaction

    Monitor/Modify Tx

    sotatercept + oxaliplatin

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe (additive effects)

  • oxaprozin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    sotatercept + oxaprozin

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective oxaprozin dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • pacritinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    pacritinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + pacritinib

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • paroxetine
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    paroxetine
    1 interaction

    Monitor/Modify Tx

    sotatercept + paroxetine

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • pazopanib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    sotatercept + pazopanib

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • pegaspargase
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    pegaspargase
    1 interaction

    Monitor/Modify Tx

    sotatercept + pegaspargase

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of bleeding (including severe), thromboembolism (additive effects)

  • penicillin G
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    penicillin G
    1 interaction

    Monitor/Modify Tx

    sotatercept + penicillin G

    monitor platelets, bleeding s/sx, especially w/ large penicillin G doses and/or concomitant renal impairment: combo may incr. risk of bleeding, including severe (additive effects)

  • pentosan polysulfate sodium
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    pentosan polysulfate sodium
    1 interaction

    Monitor/Modify Tx

    sotatercept + pentosan polysulfate sodium

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • pentoxifylline
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    pentoxifylline
    1 interaction

    Monitor/Modify Tx

    sotatercept + pentoxifylline

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • piperacillin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    piperacillin
    1 interaction

    Monitor/Modify Tx

    sotatercept + piperacillin

    monitor platelets, bleeding s/sx, especially w/ prolonged piperacillin tx and/or concomitant renal impairment: combo may incr. risk of bleeding, including severe (additive effects)

  • piroxicam
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    sotatercept + piroxicam

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective piroxicam dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • pirtobrutinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    pirtobrutinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + pirtobrutinib

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe or life-threatening (additive effects)

  • plasminogen, human
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    plasminogen, human
    1 interaction

    Monitor/Modify Tx

    sotatercept + plasminogen, human

    monitor platelets, bleeding s/sx, especially during and x4h after plasminogen infusion: combo may incr. risk of GI or other bleeding, including severe (additive effects)

  • pomalidomide
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    pomalidomide
    1 interaction

    Monitor/Modify Tx

    sotatercept + pomalidomide

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ponatinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + ponatinib

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • porfimer
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    porfimer
    1 interaction

    Monitor/Modify Tx

    sotatercept + porfimer

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • pralsetinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    pralsetinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + pralsetinib

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • prasugrel
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    prasugrel
    1 interaction

    Monitor/Modify Tx

    sotatercept + prasugrel

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • progesterone (hormone replacement)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    progesterone (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    sotatercept + progesterone (hormone replacement)

    monitor Hgb, thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • progesterone vaginal (hormone replacement)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    progesterone vaginal (hormone replacement)
    1 interaction

    Monitor/Modify Tx

    sotatercept + progesterone vaginal (hormone replacement)

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • prothrombin complex concentrate (human)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    prothrombin complex concentrate (human)
    1 interaction

    Monitor/Modify Tx

    sotatercept + prothrombin complex concentrate (human)

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • raloxifene
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    raloxifene
    1 interaction

    Monitor/Modify Tx

    sotatercept + raloxifene

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ramucirumab
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    sotatercept + ramucirumab

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • ranibizumab
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ranibizumab
    1 interaction

    Monitor/Modify Tx

    sotatercept + ranibizumab

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of thromboembolism, ocular hemorrhage (additive effects)

  • regorafenib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    regorafenib
    1 interaction

    Monitor/Modify Tx

    sotatercept + regorafenib

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe or life-threatening (additive effects)

  • remibrutinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    remibrutinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + remibrutinib

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • resveratrol
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    resveratrol
    1 interaction

    Monitor/Modify Tx

    sotatercept + resveratrol

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • reteplase
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    reteplase
    1 interaction

    Monitor/Modify Tx

    sotatercept + reteplase

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • revakinagene taroretcel
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    revakinagene taroretcel
    1 interaction

    Monitor/Modify Tx

    sotatercept + revakinagene taroretcel

    monitor platelets, bleeding s/sx: combo may incr. risk of ocular hemorrhage (additive effects)

  • Rho(D) immune globulin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    Rho(D) immune globulin
    1 interaction

    Monitor/Modify Tx

    sotatercept + Rho(D) immune globulin

    monitor Hgb, thrombosis s/sx; use lowest Rho(D) immune globulin infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • ritlecitinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ritlecitinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + ritlecitinib

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • rivaroxaban
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    rivaroxaban
    1 interaction

    Monitor/Modify Tx

    sotatercept + rivaroxaban

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • romiplostim
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    romiplostim
    1 interaction

    Monitor/Modify Tx

    sotatercept + romiplostim

    monitor Hgb, platelets, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ruxolitinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ruxolitinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + ruxolitinib

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ruxolitinib topical
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ruxolitinib topical
    1 interaction

    Monitor/Modify Tx

    sotatercept + ruxolitinib topical

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • salsalate
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    sotatercept + salsalate

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • saw palmetto
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    saw palmetto
    1 interaction

    Monitor/Modify Tx

    sotatercept + saw palmetto

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • segesterone (contraceptive)
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    segesterone (contraceptive)
    1 interaction

    Monitor/Modify Tx

    sotatercept + segesterone (contraceptive)

    monitor Hgb, thrombosis s/sx, especially w/ concomitant estrogen use: combo may incr. risk of thromboembolism (additive effects)

  • selpercatinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    selpercatinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + selpercatinib

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • selumetinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    selumetinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + selumetinib

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects, antiplatelet and anticoagulant effects augmented by vitamin E content in selumetinib capsules)

  • sepiapterin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    sepiapterin
    1 interaction

    Monitor/Modify Tx

    sotatercept + sepiapterin

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • sertraline
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    sertraline
    1 interaction

    Monitor/Modify Tx

    sotatercept + sertraline

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • sipuleucel-T
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    sipuleucel-T
    1 interaction

    Monitor/Modify Tx

    sotatercept + sipuleucel-T

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • sirolimus albumin-bound
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    sirolimus albumin-bound
    1 interaction

    Monitor/Modify Tx

    sotatercept + sirolimus albumin-bound

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • sodium tetradecyl sulfate
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    sodium tetradecyl sulfate
    1 interaction

    Monitor/Modify Tx

    sotatercept + sodium tetradecyl sulfate

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • sorafenib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    sorafenib
    1 interaction

    Monitor/Modify Tx

    sotatercept + sorafenib

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe or life-threatening (additive effects)

  • sulindac
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    sotatercept + sulindac

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective sulindac dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • sunitinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + sunitinib

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including severe or life-threatening (additive effects)

  • tamoxifen
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    tamoxifen
    1 interaction

    Monitor/Modify Tx

    sotatercept + tamoxifen

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • temsirolimus
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    temsirolimus
    1 interaction

    Monitor/Modify Tx

    sotatercept + temsirolimus

    monitor platelets, bleeding signs/symptoms: combo may incr. risk of GI or other bleeding, including severe (additive effects)

  • tenecteplase
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    tenecteplase
    1 interaction

    Monitor/Modify Tx

    sotatercept + tenecteplase

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • testosterone
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    sotatercept + testosterone

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • thalidomide
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    thalidomide
    1 interaction

    Monitor/Modify Tx

    sotatercept + thalidomide

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • ticagrelor
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ticagrelor
    1 interaction

    Monitor/Modify Tx

    sotatercept + ticagrelor

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • tipranavir
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    tipranavir
    1 interaction

    Monitor/Modify Tx

    sotatercept + tipranavir

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • tirofiban
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    tirofiban
    1 interaction

    Monitor/Modify Tx

    sotatercept + tirofiban

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • tisotumab vedotin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    tisotumab vedotin
    1 interaction

    Monitor/Modify Tx

    sotatercept + tisotumab vedotin

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • tivozanib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    sotatercept + tivozanib

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • tofacitinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    tofacitinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + tofacitinib

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • tolmetin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    sotatercept + tolmetin

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective tolmetin dose, shortest effective tx duration: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • toremifene
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    toremifene
    1 interaction

    Monitor/Modify Tx

    sotatercept + toremifene

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • tovorafenib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    tovorafenib
    1 interaction

    Monitor/Modify Tx

    sotatercept + tovorafenib

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • trametinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + trametinib

    monitor Hgb, platelets, bleeding or thrombosis s/sx, especially in combo w/ dabrafenib: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • trazodone
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    trazodone
    1 interaction

    Monitor/Modify Tx

    sotatercept + trazodone

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • treprostinil
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    treprostinil
    1 interaction

    Monitor/Modify Tx

    sotatercept + treprostinil

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • tretinoin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    tretinoin
    1 interaction

    Monitor/Modify Tx

    sotatercept + tretinoin

    monitor Hgb, thrombosis s/sx, especially during 1st month of tretinoin use: combo may incr. risk of thromboembolism (additive effects)

  • upadacitinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    upadacitinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + upadacitinib

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of GI or other bleeding (including severe), thromboembolism (additive effects)

  • vaccinia immune globulin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    vaccinia immune globulin
    1 interaction

    Monitor/Modify Tx

    sotatercept + vaccinia immune globulin

    use alternative or monitor Hgb, thrombosis s/sx; use lowest vaccinia immune globulin concentration and infusion rate possible: combo may incr. risk of thromboembolism (additive effects)

  • vadadustat
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    sotatercept + vadadustat

    monitor Hgb, platelets, bleeding or thrombosis s/sx; use lowest effective vadadustat dose: combo may incr. risk of thromboembolism, GI or other bleeding, including severe (additive effects)

  • valoctocogene roxaparvovec
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    valoctocogene roxaparvovec
    1 interaction

    Monitor/Modify Tx

    sotatercept + valoctocogene roxaparvovec

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • valproic acid
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    valproic acid
    1 interaction

    Monitor/Modify Tx

    sotatercept + valproic acid

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • vamorolone
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    sotatercept + vamorolone

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • vandetanib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    vandetanib
    1 interaction

    Monitor/Modify Tx

    sotatercept + vandetanib

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • varicella zoster immune globulin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    varicella zoster immune globulin
    1 interaction

    Monitor/Modify Tx

    sotatercept + varicella zoster immune globulin

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • venlafaxine
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    venlafaxine
    1 interaction

    Monitor/Modify Tx

    sotatercept + venlafaxine

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • vilazodone
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    vilazodone
    1 interaction

    Monitor/Modify Tx

    sotatercept + vilazodone

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • vinpocetine
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    vinpocetine
    1 interaction

    Monitor/Modify Tx

    sotatercept + vinpocetine

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe (additive effects)

  • von Willebrand factor
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    von Willebrand factor
    1 interaction

    Monitor/Modify Tx

    sotatercept + von Willebrand factor

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • vorapaxar
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    vorapaxar
    1 interaction

    Monitor/Modify Tx

    sotatercept + vorapaxar

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • vorinostat
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    vorinostat
    1 interaction

    Monitor/Modify Tx

    sotatercept + vorinostat

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

  • vortioxetine
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    vortioxetine
    1 interaction

    Monitor/Modify Tx

    sotatercept + vortioxetine

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects, antiplatelet effects augmented by inhibition of platelet serotonin uptake)

  • warfarin
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    warfarin
    1 interaction

    Monitor/Modify Tx

    sotatercept + warfarin

    monitor INR, platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (synergistic effects)

  • willow bark
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    willow bark
    1 interaction

    Monitor/Modify Tx

    sotatercept + willow bark

    monitor platelets, bleeding s/sx: combo may incr. risk of GI or other bleeding, including life-threatening (additive effects, willow bark may contain salicylates)

  • zanubrutinib
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    zanubrutinib
    1 interaction

    Monitor/Modify Tx

    sotatercept + zanubrutinib

    monitor platelets, bleeding s/sx: combo may incr. risk of bleeding, including severe or life-threatening (additive effects)

  • ziv-aflibercept
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    sotatercept + ziv-aflibercept

    monitor Hgb, platelets, bleeding or thrombosis s/sx: combo may incr. risk of GI or other bleeding (including severe or life-threatening), thromboembolism (additive effects)

  • zopapogene imadenovec
  • Winrevair (sotatercept-csrk) (sotatercept)
    +
    zopapogene imadenovec
    1 interaction

    Monitor/Modify Tx

    sotatercept + zopapogene imadenovec

    monitor Hgb, thrombosis s/sx: combo may incr. risk of thromboembolism (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@7264470
  • erythrocytosis
  • thrombocytopenia, severe
  • bleeding, severe
  • impaired fertility (animal studies)

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@1be5709e
  • Hgb incr.
  • Plt decr.
  • headache
  • epistaxis
  • rash
  • telangiectasia
  • diarrhea
  • dizziness
  • erythema
  • thrombocytopenia, severe
  • bleeding, severe
  • intrapulmonary right-to-left shunting

Safety/Monitoring .

Monitoring Parameters
pregnancy test at baseline; Hgb, Plt at baseline, before each dose for 1st 5 doses or longer if unstable levels, then periodically and before each tx reinitiation

Pregnancy/Lactation .

Pregnancy

Clinical Summary

avoid use during pregnancy; no human data available; risk of embryo-fetal death, decr. fetal birth weight, and delayed ossification based on animal data at 0.6x and 4x MRHD

Pregnancy Reporting

report any suspected fetal exposure to Merck Sharp & Dohme, LLC adverse event reporting line at 1-877-888-4231

Individuals of Reproductive Potential

avoid pregnancy by using effective contraception during tx and for at least 4mo after D/C in patients of childbearing potential

Lactation

Clinical Summary

avoid breastfeeding during tx and x4mo after D/C; no human data to assess risk of infant harm or effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@2bd15253

Metabolism: for sotatercept: catabolism; CYP450: unknown

Excretion: for sotatercept: unknown; Half-life: 24 days

Subclass: Pulmonary Arterial Hypertension (PAH)

Mechanism of Action
for sotatercept: binds to activin A and other TGF-b superfamily ligands, inhibiting activin signaling and modulating vascular proliferation

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Merck & Co., Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@7030ced3

DEA/FDA: Rx

Retail Price

This information is currently not available for this drug.

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information